BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6437694)

  • 1. Effect of D,L-alpha-difluoromethylornithine on murine mammary carcinogenesis.
    Thompson HJ; Herbst EJ; Meeker LD; Minocha R; Ronan AM; Fite R
    Carcinogenesis; 1984 Dec; 5(12):1649-51. PubMed ID: 6437694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of concentration of D,L-2-difluoromethylornithine on murine mammary carcinogenesis.
    Thompson HJ; Meeker LD; Herbst EJ; Ronan AM; Minocha R
    Cancer Res; 1985 Mar; 45(3):1170-3. PubMed ID: 3918790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tamoxifen and D,L-2-difluoromethylornithine on the growth, ornithine decarboxylase activity and polyamine content of mammary carcinomas induced by 1-methyl-1-nitrosourea.
    Thompson HJ; Ronan AM; Ritacco KA; Meeker LD
    Carcinogenesis; 1986 May; 7(5):837-40. PubMed ID: 3084121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of D,L-2-difluoromethylornithine and endocrine manipulation on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea.
    Thompson HJ; Ronan AM
    Carcinogenesis; 1986 Dec; 7(12):2003-6. PubMed ID: 3096587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of DL-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, on the rat mammary tumour induced by 7,12-dimethylbenz[a]anthracene.
    Fozard JR; Prakash NJ
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Jul; 320(1):72-7. PubMed ID: 6811956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets.
    Abou-el-Ela SH; Prasse KW; Farrell RL; Carroll RW; Wade AE; Bunce OR
    Cancer Res; 1989 Mar; 49(6):1434-40. PubMed ID: 2538226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metastatic Lewis lung carcinoma with DL-alpha-difluoromethylornithine.
    Bartholeyns J
    Eur J Cancer Clin Oncol; 1983 Apr; 19(4):567-72. PubMed ID: 6407845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemotherapeutic potential of polyamine antimetabolites.
    Kingsnorth AN
    Ann R Coll Surg Engl; 1986 Mar; 68(2):76-81. PubMed ID: 3082276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of ovulation in the rat by DL-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase.
    Carpenter JR; Fozard JR
    Eur J Pharmacol; 1982 May; 80(2-3):263-6. PubMed ID: 6809478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyamines as mediators of estrogen action on the growth of experimental breast cancer in rats.
    Manni A; Wright C
    J Natl Cancer Inst; 1984 Aug; 73(2):511-4. PubMed ID: 6431170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor promotion by DL-alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase.
    Verma AK
    Basic Life Sci; 1990; 52():195-204. PubMed ID: 2109593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alpha-difluoromethylornithine on the growth of experimental Wilms' tumor and renal adenocarcinoma.
    Kingsnorth AN; McCann PP; Diekema KA; Ross JS; Malt RA
    Cancer Res; 1983 Sep; 43(9):4031-4. PubMed ID: 6307502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention and chemotherapy by inhibition of ornithine decarboxylase activity and polyamine synthesis: colonic, pancreatic, mammary, and renal carcinomas.
    Malt RA; Kingsnorth AN; Lamuraglia GM; Lacaine F; Ross JS
    Adv Enzyme Regul; 1985; 24():93-102. PubMed ID: 3939097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the irreversible ornithine decarboxylase inhibitor, alpha-difluoromethylornithine, aflatoxin B1, and choline deficiency on hepatocarcinogenesis.
    Sondergaard D; Taylor F; Newberne PM
    Toxicol Pathol; 1985; 13(1):36-49. PubMed ID: 2412277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on prostatic growth of 2-difluoromethylornithine, an effective inhibitor of ornithine decarboxylase.
    Danzin C; Claverie N; Wagner J; Grove J; Koch-Weser J
    Biochem J; 1982 Jan; 202(1):175-81. PubMed ID: 6177318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to cancer chemoprevention with difluoromethylornithine and selenite.
    Ip C; Thompson HJ
    J Natl Cancer Inst; 1989 Jun; 81(11):839-43. PubMed ID: 2498524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tamoxifen and alpha-difluoromethylornithine on clones of nitrosomethylurea-induced rat mammary tumor cells grown in soft agar culture.
    Manni A; Wright C
    Cancer Res; 1983 Mar; 43(3):1084-6. PubMed ID: 6402297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-difluoromethylornithine on pancreatic growth induced by caerulein.
    Benrezzak O; Morisset J
    Regul Pept; 1984 Oct; 9(3):143-53. PubMed ID: 6084857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ileal and colonic ornithine decarboxylase activity by alpha-difluoromethylornithine in rats: transient atrophic changes and loss of postresectional adaptive growth.
    Kingsnorth AN; Abu-Khalaf M; LaMuraglia GM; McCann PP; Diekema KA; Ross JS; Malt RA
    Surgery; 1986 Jun; 99(6):721-7. PubMed ID: 2424111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ornithine decarboxylase and mucosal growth in response to feeding.
    Tabata K; Johnson LR
    Am J Physiol; 1986 Aug; 251(2 Pt 1):G270-4. PubMed ID: 3090896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.